precision-chemistry
(2)
Kimia Therapeutics
Kimia Therapeutics is a Berkeley-based biotech building ATLAS, a drug-discovery platform that pairs nanoliter-scale high-throughput precision chemistry with machine learning and genome editing to map the druggable space at single-atom resolution. Spun out of Carmot Therapeutics in 2023 and backed by $55M in Series A funding, Kimia is using its chemical atlas to advance therapeutic programs in cancer and immunology.
Numat
Numat is a Chicago-based advanced-materials company and the first to commercialize metal-organic frameworks (MOFs) at industrial scale. Its molecularly engineered, programmable 'sponges' capture, store, and separate hazardous chemicals for semiconductor, defense, and energy customers, reducing the impact of chemical products and processes on human health and the environment.